WITHDRAWN: Efficacy and Safety of Mycophenolate Mofetil Versus Levamisole in Children and Adolescents With Idiopathic Nephrotic Syndrome: Results of a Randomized Clinical Trial

Biswanath Basu; Rajendra Pandey; T K S Mahapatra; Nirmal Mondal; Franz Schaefer

doi:10.1053/j.ajkd.2015.04.048

WITHDRAWN: Efficacy and Safety of Mycophenolate Mofetil Versus Levamisole in Children and Adolescents With Idiopathic Nephrotic Syndrome: Results of a Randomized Clinical Trial

Am J Kidney Dis. 2015 Jun 9:S0272-6386(15)00762-3. doi: 10.1053/j.ajkd.2015.04.048. Online ahead of print.

Authors

Biswanath Basu¹, Rajendra Pandey², T K S Mahapatra³, Nirmal Mondal⁴, Franz Schaefer⁵

Affiliations

¹ Division of Pediatric Nephrology, NRS Medical College & Hospital, Kolkata, India; Department of Pediatrics, NRS Medical College & Hospital, Kolkata, India.
² Department of Nephrology, Institute of Post Graduate Medical Education & Research, Kolkata, India.
³ Department of Pediatrics, NRS Medical College & Hospital, Kolkata, India.
⁴ Department of Community Medicine & Statistics, NRS Medical College & Hospital, Kolkata, India.
⁵ Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.

PMID: 26071057
DOI: 10.1053/j.ajkd.2015.04.048

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.